Releases - Biotage

View:

2006

 

Found press releases

 

Interim report January – September 2006

10/23/2006 5:22 AM EST
Biotage reports its best result ever
• The company has been strongly aimed at the integration of previously acquired units with a focus on organic growth, gross margin and cost efficiency. For the third quarter Biotage reports its best result ever, with a positive operating result as well as a positive result after tax.

• Net sales increased by 6%in the third quarter and amounted to 133.9 MSEK (126.6 MSEK...

Interim report January – June 2006

8/8/2006 5:05 AM EST
- Net sales increased by 37 percent in the second quarter and amounted to 128.3 MSEK (93.5). In the period January – June 2006 sales increased by 50% to 249.0 MSEK (165.4). Pro-forma the sales increase in the second quarter was approx. 12 percent at constant exchange rates. In the period January – June it was approx. 11%.
- The operating result for the second quarter improved by 13.3 MSEK and amounted to
–2.2...

Resolutions at the Annual Shareholders’ Meeting in Biotage AB on April 27, 2006

4/27/2006 12:36 PM EST
At the Annual Shareholders’ Meeting held in Biotage AB (Reg. No. 556539-3138) on April 27, 2006, the following resolutions were passed, among others.

Appropriation of the company’s result
The Shareholders’ Meeting resolved, in accordance with the proposal by the Board of Directors and the Managing Director, that the company’s accumulated loss shall be balanced on new account.

Board of Directors etc.
The...

Interim report January – March 2006

4/27/2006 9:29 AM EST
• Net sales in the first quarter 2006 increased by 68 percent and amounted to 120.6 MSEK (72.0). The pro-forma sales increase was approx. 9 percent at comparable exchange rates.
• The operating result for the first quarter improved by 10 MSEK and amounted to –12.2 MSEK (-22.2).
• The result after tax for the first quarter amounted to -20.8 MSEK (-13.5).
• Earnings per share in the first quarter amounted to -0.24 SEK...

Biotage’s Annual Report 2005 in Swedish published

4/7/2006 2:00 AM EST
The Biotage Annual Report for 2005 in Swedish is available as a PDF file on the Group’s web site as of today, at www.biotage.com. The printed Swedish version is now being distributed to the shareholders and can also be ordered from Biotage at telephone +46 18 56 59 00. The English edition of the Annual Report will be available in a few weeks.

NOTICE OF ANNUAL GENERAL MEETING OF BIOTAGE AB

3/28/2006 1:53 AM EST
UNOFFICIAL TRANSLATION – This notice of the Annual General Meeting was prepared in Swedish and translated into English. In the event of any discrepancies between the Swedish original and the English translation, the former shall have precedence.
Shareholders in Biotage AB are hereby invited to attend the Annual General Meeting, to be held on Thursday, April 27, 2006, at 5:00 p.m., at the head office of Biotage...

Proposals for Annual General Meeting

3/23/2006 3:01 AM EST
The Board of Directors of Biotage AB proposes the Annual General Meeting on April 27, 2006, to:
• authorize the Board to issue shares and/or convertibles
• resolve on the adoption of a global employee stock option program
• resolve on a hedging arrangement for the adoption of the employee stock option program (authorization for the Board to issue warrants)
Authorization for the Board of Directors to issue...

Biotage Makes a Change in Top Management after Business Area President resigns

2/28/2006 3:15 AM EST
UPPSALA, SWEDEN. The life science company Biotage, listed on the O-list of the Stockholm stock exchange, makes a change in its top management. David Patteson, President of the business area Discovery Chemistry has decided to seek new challenges elsewhere. He will leave the company on 1 April 2006.

David Patteson has been with Biotage for seven years during which time he has very successfully built up the Global...

Global option program for employees in Biotage

2/22/2006 3:16 AM EST
The board of directors has, in accordance with an authorisation from the annual shareholders’ meeting held on April 27, 2005, adopted a global option program for employees within the Biotage group – Biotage AB Global Share Option Plan 2005.

The board of directors has further, in accordance with an authorisation from the above mentioned shareholders’ meeting, resolved to allot 549 600 employee stock options under...

Torben Jörgensen New CEO at Biotage

2/9/2006 8:24 AM EST
UPPSALA, SWEDEN. The life science company Biotage, listed on the O-list of the Stockholm stock exchange, makes a further strategic move to integrate its acquired businesses and to optimize the product portfolio, with the intention to focus on organic growth.

As a part of this process, Torben Jörgensen will succeed Jeff Bork as the CEO of the company. For the last four years, Torben Jörgensen was the CEO of...

Biotage

Biotage accelerates the drug discovery and development process and increases the knowledge of the importance of the genetic make-up by providing complete solutions for medicinal chemistry research and applied genetic ana...

View more


  CONTACT